By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PharmaMar S.A. 

Pol Ind. la Mina Avenida de los Reyes, 1

Colmenar Viejo  Madrid  28770  Spain
Phone: 34-91-8466000 Fax: 34-91-8466001


SEARCH JOBS








Company News
PharmaMar Presents Positive Results With Its Conjugated Antibody MI130110 In CD13-Expressing Tumor-Cells 12/1/2016 11:19:12 AM
PharmaMar Begins A Phase I Study Of PM1183 In Japan For The Treatment Of Solid Tumors 11/28/2016 8:11:05 AM
PharmaMar Appoints Pascal Besman As Chief Operating Officer Of PharmaMar U.S. 11/16/2016 8:24:56 AM
The EMA Accepts To Assess The Marketing Authorization Application From PharmaMar For Aplidin 10/28/2016 11:51:06 AM
PharmaMar Announces The Opening Of A New Affiliate In Austria 10/24/2016 10:29:25 AM
PharmaMar Completes The Patient Recruitment For The "CORAIL" Phase III Pivotal Study With PM1183 10/18/2016 11:57:44 AM
PharmaMar Announces Positive Results From Its Phase II Study With Lurbinectedin In BRCA 1/2 - Associated Metastatic Breast Cancer At The ESMO 2016 Congress 10/10/2016 8:36:47 AM
PharmaMar Shows New Clinical Data On Yondelis And Lurbinectedin At ESMO 2016 10/6/2016 9:43:41 AM
PharmaMar And Boryung Pharmaceuticals Co., Ltd. Sign A Licensing Agreement For Aplidin (Plitidepsin) In Korea 10/4/2016 7:37:55 AM
PharmaMar Submits MAA To EMA For Aplidin For The Treatment Of Multiple Myeloma 9/22/2016 8:16:45 AM
12345
//-->